Flutter Entertainment plc (the "Company")
Effective Date Announcement
NEW YORK and DUBLIN, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Further to the announcement made on June 12, 2026, Flutter Entertainment plc ("Flutter" or the "Company") (NYSE: FLUT) today announces that: (i) the listing of the Company's shares on the Official List of the U.K. Financial Conduct Authority; and (ii) the admission to trading of those shares on the main market for listed securities of the London Stock Exchange, have now been cancelled with effect from 08:00 U.K. time today, August 3, 2026. Flutter's shares are now only listed on the New York Stock Exchange.
To assist shareholders, the Company has prepared answers to Frequently Asked Questions, which are available on the Company's website and accessible here.
About Flutter Entertainment plc
Flutter is the world's leading online sports betting and iGaming operator, with a market leading position in the US and across the world. Our ambition is to leverage our size and our challenger mindset to change our industry for the better. By Changing the Game, we believe we can deliver long-term growth while promoting a positive, sustainable future for all our stakeholders. We are well-placed to do so through the distinctive, global advantages of the Flutter Edge, which gives our brands access to group-wide benefits, as well as our clear vision for sustainability through our Positive Impact Plan.
Flutter operates a diverse portfolio of leading online sports betting and iGaming brands including FanDuel, Sky Betting & Gaming, Sportsbet, PokerStars, Paddy Power, Sisal, Snai, tombola, Betfair, MaxBet, Junglee Games, Adjarabet and Betnacional.
To learn more about Flutter, please visit our website at www.flutter.com.
Enquiries
Investor Relations: [email protected]
Media Relations: [email protected]
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.